Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Effects of Nimodipine in Schizophrenia
NCT03671525Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Nimodipine with Placebo (2 arms). Primary endpoints: Brain activity as assessed by BOLD fMRI, Changes in Visual Learning and Memory and 2 more. Started Oct 2018; status: completed.
02
Drugs
nimodipine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03671525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671525.